Citadel Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Hold |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $12M | Buy |
|
|||||
|
2020
Q3 | $195K | Sell |
|
|||||
|
2020
Q2 | $809K | Buy |
|
|||||
|
2020
Q1 | $292K | Sell |
|
|||||
|
2019
Q4 | $698K | Sell |
|
|||||
|
2019
Q3 | $851K | Buy |
|
|||||
|
2019
Q2 | $950K | Buy |
|
|||||
|
2019
Q1 | $358K | Sell |
|
|||||
|
2018
Q4 | $1.54M | Sell |
|
|||||
|
2018
Q3 | $3.42M | Buy |
|
|||||
|
2018
Q2 | $2.33M | Buy |
|
|||||
|
2018
Q1 | $1.29M | Sell |
|
|||||
|
2017
Q4 | $1.83M | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $5.57M | Buy |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $368K | Sell |
|
|||||
|
2015
Q4 | $11M | Buy |
|
|||||
|
2015
Q3 | $3.21M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $472K | Buy |
|
|||||
|
2014
Q3 | $141K | Buy |
|